These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 6970620

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus.
    Stutman O.
    Nature; 1975 Jan 10; 253(5487):142-4. PubMed ID: 1110765
    [No Abstract] [Full Text] [Related]

  • 29. The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
    Gershwin ME, Castles JJ, Ahmed A, Makishima R.
    J Immunol; 1978 Dec 10; 121(6):2292-8. PubMed ID: 82580
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: no requirement for exogenous C5.
    Fuson EW, Walia AS, Cox BA, Lamon EW.
    Clin Immunol Immunopathol; 1979 Sep 10; 14(1):35-46. PubMed ID: 477041
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Combined immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Giuliani F, Casazza AM, Di Marco A.
    Biomedicine; 1973 Sep 10; 18(5):387-92. PubMed ID: 4752705
    [No Abstract] [Full Text] [Related]

  • 35. Moloney murine sarcoma virus oncogenesis in T-lymphocyte-deprived mice: biologic and immunologic studies.
    Collavo D, Zanovello P, Leuchars E, Davies AJ, Chieco-Bianchi L, Biasi G.
    J Natl Cancer Inst; 1980 Jan 10; 64(1):97-104. PubMed ID: 6243378
    [No Abstract] [Full Text] [Related]

  • 36. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ, Jenkinson EJ, Owen JJ.
    Immunology; 1987 Jul 10; 61(3):317-20. PubMed ID: 2956180
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.